SCHEMBL5456420

SCHEMBL5456420

COCCCn1c(N)nc2ccccc21

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR4 P61073 1/20 0.73
TLR8 Q9NR97 3/20 0.70
POLB P06746 1/20 0.65
HTT P42858 3/20 0.59
CYP1A2 P05177 1/20 0.59
CYP2D6 P10635 1/20 0.59
KMT2A Q03164 3/20 0.56
TP53 P04637 2/20 0.56
CXCL8 P10145 1/20 0.56
NOD1 Q9Y239 1/20 0.56
HPGD P15428 2/20 0.55
MAPT P10636 1/20 0.55
CXCR5 P32302 1/20 0.55
OPRM1 P35372 1/20 0.55
APLNR P35414 1/20 0.55
OPRD1 P41143 1/20 0.55
CCR6 P51684 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
NPSR1 Q6W5P4 1/20 0.55
TLR9 Q9NR96 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15595665 0.91 POLB (0.69) CXCR4TLR8POLBHTTCYP1A2
SCHEMBL7164854 0.85 CXCR4 (0.93) CXCR4TLR8POLBHTTCYP1A2
SCHEMBL6196399 0.85 CXCR4 (1.00) CXCR4TLR8POLBHTTCYP1A2
SCHEMBL14447553 0.84 CXCR4 (0.96) CXCR4TLR8POLBHTTCYP1A2
SCHEMBL6197634 0.84 CXCR4 (0.96) CXCR4TLR8POLBHTTCYP1A2
SCHEMBL2343059 0.83 TLR8 (1.00) CXCR4TLR8POLBHTTCYP1A2
SCHEMBL8314046 0.82 LMNA (0.56) CXCR4TLR8HTTKMT2ATP53
SCHEMBL8313701 0.82 TSHR (0.54) CXCR4TLR8POLBHTTKMT2A
SCHEMBL6199065 0.82 CXCR4 (0.85) CXCR4TLR8POLBHTTCYP1A2
SCHEMBL1170110 0.81 TLR8 (1.00) CXCR4TLR8POLBHTTCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070232673-A1 2-Imino-benzimidazoles ABBOTT LABORATORIES 2007-10-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070232673-A1 2-Imino-benzimidazoles CYP2C19, UGT2B7, UGT2B17 CXCR4 3445/4885TLR8 3837/4885POLB 2088/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.